Fifth Industry Standing Group (ISG) meeting

EMA is holding the fifth meeting of the Industry Standing Group (ISG). This forum for interaction has been established as part of the EMA's continuous improvement for engagement with industry stakeholders. It aims to:

• facilitate regular exchange of views;
• promote dialogue;
• receive feedback on EMA’s Mandate extension implementation activities such as those related to medicines and medical device shortages, the status of the activities of the medical device expert panels and ETF implementation update.

The ISG is also discussing high level progress development updates of other topics of common interest for the Agency and the pharmaceutical industry (such as Pharma legislation review, ACT EU and CTIS implementation, new EMA Working Party governance and Quality Innovation Group).